Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1984 Apr;49(4):477–484. doi: 10.1038/bjc.1984.75

Proliferative patterns of lymphocytes in lymph nodes during tumour development: involvement of T and B cell areas.

M Bertschmann, R Markwalder-Hartenbach, E Pedrinis, M W Hess, H Cottier
PMCID: PMC1976764  PMID: 6424695

Abstract

DNA-synthetizing lymphocytes were identified in the lymph nodes regional and more distal to the site of developing P-815 tumours by incorporation of [3H]-thymidine followed by autoradiography of lymph node sections. It appeared that not only T but also B cell areas of draining and to a lesser extent of distal lymph nodes were stimulated by the growing tumour. This result was unexpected since neither humoral nor tumour cell-bound antibody could be identified so far as a functional correlate of B cell stimulation. In general the proliferative response of lymphocytes followed a biphasic pattern with an early peak of reactivity on days 2-3 and a second peak around day 12-15 after tumour cell inoculation. In the draining (axillary) lymph node the second peak of reactivity was suppressed, possibly as a consequence of metastatic tumour cells in this node when tumour cells were inoculated in the flank. The pattern of lymphocyte stimulation revealed larger individual variations after tumour cell inoculation in the flank than the foot pad. These results were associated with a slower and less regular drainage of carbon particles from the flank to the axillary and exceptionally the brachial lymph node than from the foot pad to the popliteal node after injection of India ink.

Full text

PDF
477

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bertschmann M., Lüscher E. F. Stimulation of different pathways of T-cell functions by syngeneic tumor cells and soluble membrane proteins. Cell Immunol. 1983 May;78(1):13–22. doi: 10.1016/0008-8749(83)90255-1. [DOI] [PubMed] [Google Scholar]
  2. Bertschmann M., Schären B., Lüscher E. F. Correlation of in vivo and in vitro immune reactions against the intradermally developing P-815 mastocytoma in the syngeneic mouse. Immunobiology. 1980 Jan;156(4-5):382–399. doi: 10.1016/S0171-2985(80)80072-6. [DOI] [PubMed] [Google Scholar]
  3. Biddison W. E., Palmer J. C. Development of tumor cell resistance to syngeneic cell-mediated cytotoxicity during growth of ascitic mastocytoma P815Y. Proc Natl Acad Sci U S A. 1977 Jan;74(1):329–333. doi: 10.1073/pnas.74.1.329. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Buerki H., Cottier H., Hess M. W., Laissue J., Stoner R. D. Distinctive medullary and germinal center proliferative patterns in mouse lymph nodes after regional primary and secondary stimulation with tetanus toxoid. J Immunol. 1974 Jun;112(6):1961–1970. [PubMed] [Google Scholar]
  5. Canty T. G., Wunderlich J. R. Quantitative assessment of cellular and humoral responses to skin and tumor allografts. Transplantation. 1971 Feb;11(2):111–116. doi: 10.1097/00007890-197102000-00001. [DOI] [PubMed] [Google Scholar]
  6. Check I. J., Cobb M., Hunter R. L. The relationship between cytotoxicity and prognostically significant histologic changes in lymph nodes from patients with cancer of the breast. Am J Pathol. 1980 Feb;98(2):325–338. [PMC free article] [PubMed] [Google Scholar]
  7. Clemetson K. J., Bertschmann M., Lüscher E. F. Tumour-associated antigens of the mouse P-815 mastocytoma cell: evidence for an antigen with H-2-like characteristics. Mol Immunol. 1981 Feb;18(2):135–141. doi: 10.1016/0161-5890(81)90079-1. [DOI] [PubMed] [Google Scholar]
  8. DUNN T. B., POTTER M. A transplantable mast-cell neoplasm in the mouse. J Natl Cancer Inst. 1957 Apr;18(4):587–601. [PubMed] [Google Scholar]
  9. Dye E. S., North R. J. T cell-mediated immunosuppression as an obstacle to adoptive immunotherapy of the P815 mastocytoma and its metastases. J Exp Med. 1981 Oct 1;154(4):1033–1042. doi: 10.1084/jem.154.4.1033. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Fisher B., Saffer E., Fisher E. R. Studies concerning the regional lymph node in cancer. IV. Tumor inhibition by regional lymph node cells. Cancer. 1974 Mar;33(3):631–636. doi: 10.1002/1097-0142(197403)33:3<631::aid-cncr2820330307>3.0.co;2-g. [DOI] [PubMed] [Google Scholar]
  11. Fisher E. R., Reidbord H. E., Fisher B. Studies concerning the regional lymph node in cancer. V. Histologic and ultrastructural findings in regional and nonregional nodes. Lab Invest. 1973 Jan;28(1):126–133. [PubMed] [Google Scholar]
  12. Galili U., Klein E., Klein G., Singh Bal I. Activated T lymphocytes in infiltrates and draining lymph nodes of nasopharyngeal carcinoma. Int J Cancer. 1980 Jan 15;25(1):85–89. doi: 10.1002/ijc.2910250111. [DOI] [PubMed] [Google Scholar]
  13. Glasebrook A. L., Quintans J., Eisenberg L., Fitch F. W. Alloreactive cloned T cell lines. II. Polyclonal stimulation of B cells by a cloned helper T cell line. J Immunol. 1981 Jan;126(1):240–244. [PubMed] [Google Scholar]
  14. Gomard E., Leclerc J. C., Levy J. P. Spontaneous antilymphoma reaction of preleukaemic AKR mice is a non-T-cell killing. Nature. 1974 Aug 23;250(5468):671–673. doi: 10.1038/250671a0. [DOI] [PubMed] [Google Scholar]
  15. Green W. R. The in vitro generation of H-2-restricted cytotoxic T cells to AKR/Gross leukemia virus-induced tumors. I. Requirement for stimulation with allogeneic leukemia cells in vivo. J Immunol. 1982 Mar;128(3):1043–1049. [PubMed] [Google Scholar]
  16. Jones J. A., Robinson G., Rees R. C., Baldwin R. W. Immune response of the draining and distal lymph nodes during the progressive grwoth of a chemically-induced transplantable rat hepatoma. Int J Cancer. 1978 Feb 15;21(2):171–178. doi: 10.1002/ijc.2910210208. [DOI] [PubMed] [Google Scholar]
  17. Kanagawa O. Three different signals are required for the induction of cytolytic T lymphocytes from resting precursors. J Immunol. 1983 Aug;131(2):606–610. [PubMed] [Google Scholar]
  18. MacDonald H. R., Lees R. K. Dissociation of differentiation and proliferation in the primary induction of cytolytic T lymphocytes by alloantigens. J Immunol. 1980 Mar;124(3):1308–1313. [PubMed] [Google Scholar]
  19. Matossian-Rogers A., Rogers P. Tumour-induced changes in murine lymphocyte profiles. Br J Cancer. 1982 Sep;46(3):452–456. doi: 10.1038/bjc.1982.225. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Raulet D. H., Bevan M. J. A differentiation factor required for the expression of cytotoxic T-cell function. Nature. 1982 Apr 22;296(5859):754–757. doi: 10.1038/296754a0. [DOI] [PubMed] [Google Scholar]
  21. Röllinghoff M., Pfizenmeier K., Trostmann H., Wagner H. T cell proliferation in the mixed lymphocyte culture does not necessarily result in the generation of cytotoxic T effector cells. Eur J Immunol. 1975 Aug;5(8):560–564. doi: 10.1002/eji.1830050811. [DOI] [PubMed] [Google Scholar]
  22. Syrjänen K. J. Spleen white pulp morphology as an indicator of the immunological state in DBA/2 mice bearing mastocytoma. Exp Pathol (Jena) 1980;18(4):223–231. doi: 10.1016/s0014-4908(80)80052-4. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES